Literature DB >> 17221843

Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Gui-Min Wang1, Bruce Kovalenko, Yili Huang, David Moscatelli.   

Abstract

BACKGROUND: The regulation of the prostate size by androgens may be partly the result of androgen effects on the prostatic vasculature. We examined the effect of changes in androgen levels on the expression of a variety of angiogenic factors in the mouse prostate and determined if vascular endothelial growth factor (VEGF)-A and the angiopoietins are involved in the vascular response to androgens.
METHODS: Expression of angiogenic factors in prostate was quantitated using real-time PCR at different times after castration and after administration of testosterone to castrated mice. Angiopoietins were localized in prostate by immunohistochemistry and in situ hybridization. The roles of VEGF and the angiopoietins in regeneration of the prostate were examined in mice inoculated with cells expressing soluble VEGF receptor-2 or soluble Tie-2.
RESULTS: Castration resulted in a decrease in VEGF-A, VEGF-B, VEGF-C, placenta growth factor, FGF-2, and FGF-8 expression after 1 day. In contrast, VEGF-D mRNA levels increased. No changes in angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), hepatocyte growth factor, VEGF receptor-1, VEGF receptor-2, or tie-2 mRNA levels were observed. Administration of testosterone to castrated mice had the opposite effect on expression of these angiogenic factors. Ang-2 was expressed predominantly in prostate epithelial cells whereas Ang-1 was expressed in epithelium and smooth muscle. Inoculation of mice with cells expressing soluble VEGF receptor-2 or Tie-2 blocked the increase in vascular density normally observed after administration of testosterone to castrated mice. The soluble receptors also blocked the increase in prostate weight and proliferation of prostatic epithelial cells.
CONCLUSION: VEGF-A and angiopoietins are required for the vascular response to androgens and for the ability of the prostate to regenerate in response to androgens.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17221843      PMCID: PMC1865098          DOI: 10.1002/pros.20534

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  44 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF.

Authors:  J Holash; S J Wiegand; G D Yancopoulos
Journal:  Oncogene       Date:  1999-09-20       Impact factor: 9.867

3.  Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration.

Authors:  M Burchardt; T Burchardt; M W Chen; O R Hayek; C Knight; A Shabsigh; A de La Taille; R Buttyan
Journal:  Prostate       Date:  2000-05-15       Impact factor: 4.104

4.  Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats.

Authors:  I Franck-Lissbrant; S Häggström; J E Damber; A Bergh
Journal:  Endocrinology       Date:  1998-02       Impact factor: 4.736

5.  Regulation of Apoptosis in the Prostate Gland by Androgenic Steroids.

Authors: 
Journal:  Trends Endocrinol Metab       Date:  1999-03       Impact factor: 12.015

6.  Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts.

Authors:  R J Stewart; D Panigrahy; E Flynn; J Folkman
Journal:  J Urol       Date:  2001-02       Impact factor: 7.450

7.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

8.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

9.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2.

Authors:  P Lin; J A Buxton; A Acheson; C Radziejewski; P C Maisonpierre; G D Yancopoulos; K M Channon; L P Hale; M W Dewhirst; S E George; K G Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

View more
  11 in total

1.  Endothelial cells support the growth of prostate tissue in vivo.

Authors:  Michael Bates; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2008-06-01       Impact factor: 4.104

2.  Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor.

Authors:  Kuo-Pao Lai; Shinichi Yamashita; Spencer Vitkus; Chih-Rong Shyr; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2011-12-01

3.  Suppression of DHT-induced paracrine stimulation of endothelial cell growth by estrogens via prostate cancer cells.

Authors:  Juan Wen; Yuan Zhao; Jinghe Li; Chunyan Weng; Jingjing Cai; Kan Yang; Hong Yuan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  Prostate       Date:  2013-02-19       Impact factor: 4.104

4.  Novel methods to identify biologically relevant genes for leukemia and prostate cancer from gene expression profiles.

Authors:  Austin H Chen; Yin-Wu Tsau; Ching-Heng Lin
Journal:  BMC Genomics       Date:  2010-04-30       Impact factor: 3.969

5.  Vascular density is highest in the proximal region of the mouse prostate.

Authors:  Gui-Min Wang; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2007-06-15       Impact factor: 4.104

6.  Castration-resistant Lgr5(+) cells are long-lived stem cells required for prostatic regeneration.

Authors:  Bu-er Wang; Xi Wang; Jason E Long; Jeff Eastham-Anderson; Ron Firestein; Melissa R Junttila
Journal:  Stem Cell Reports       Date:  2015-04-30       Impact factor: 7.765

Review 7.  Anti-angiogenesis in prostate cancer: knocked down but not out.

Authors:  Marijo Bilusic; Yu-Ning Wong
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

8.  Role of androgens for urethral homeostasis.

Authors:  Matthias D Hofer; Allen F Morey
Journal:  Transl Androl Urol       Date:  2018-08

9.  Changes in Lymphangiogenesis and Vascular Endothelial Growth Factor Expression by Neo-Adjuvant Hormonal Therapy in Prostate Cancer Patients.

Authors:  Akihiro Asai; Yasuyoshi Miyata; Tomohiro Matsuo; Yohei Shida; Tomoaki Hakariya; Kojiro Ohba; Hideki Sakai
Journal:  Prostate       Date:  2016-08-16       Impact factor: 4.104

Review 10.  Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate.

Authors:  Kenichiro Ishii; Sanai Takahashi; Yoshiki Sugimura; Masatoshi Watanabe
Journal:  J Clin Med       Date:  2018-04-02       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.